Drug reimbursement up 3.6% y-o-y in H1 2017

…higher than in the first six months of 2016. The amount constitutes 45.5% of the annual plan (PLN 3.03bn or €714m). Expenditures on chemotherapy drugs amounted to PLN 290m (€68m), up 6.2% year-on-year. The amount represents 45.1% of an annual plan of PLN 644m (€152m).  

Sign up now to open the entire news item.

You are allowed to open only one news item from PMR websites.
  • 1E-mail
    (to send requested information)
  • 2Brief profile
    (required for new e-mails only)

 required fields

You must accept PMR’s Privacy Policy.